Aragonès J M, Altimiras J, Roura P, Alonso F, Bufill E, Munmany A, Alfonso S, Illa I
Servicio de Neurología, Consorci Hospitalari de Vic, Vic, Barcelona, España.
Servicio de Epidemiología Clínica e Investigación, Consorci Hospitalari de Vic, Vic, Barcelona, España.
Neurologia. 2017 Jan-Feb;32(1):1-5. doi: 10.1016/j.nrl.2014.09.007. Epub 2014 Nov 11.
The reported prevalence of myasthenia gravis ranges between 5 and 24 cases per 100,000, and people over 65years account for less than 50% of all cases. The prevalence and clinical characteristics of myasthenia gravis in the county of Osona were studied in patients younger and older than 65.
The study draws from the county-based prospective myasthenia gravis register implemented by the Neurology Department at Hospital General de Vic in 1991.
The prevalence of myasthenia gravis was 32.89×10 inhabitants (95%CI, 23.86-41.91). The standardized prevalence (European population) was 35.47×10 inhabitants (95%CI, 26.10-44.84). The ratio of women to men was 1.3. Overall, the group of patients older than 65 accounted for 62.75% of all cases. The prevalence of myasthenia gravis increased considerably in older age groups. No cases were registered among patients under 25years old, prevalence was 21.87×10 in the 25 to 64 age group, and prevalence in patients over 65 years increased to 122.35×10. The clinical characteristics prior to treatment and at the cut-off date are similar (P>.05) in patients younger than 65 and those aged 65 and older.
These figures show the highest prevalence rate reported to date. This high prevalence is due to the rate observed among patients older than 65. These results provide a new warning that myasthenia gravis may be underdiagnosed in the elderly population.
据报道,重症肌无力的患病率为每10万人中有5至24例,65岁以上的患者占所有病例的比例不到50%。本研究对奥索纳县65岁及以下和65岁以上患者的重症肌无力患病率及临床特征进行了研究。
本研究的数据来自1991年维克总医院神经科实施的基于该县的前瞻性重症肌无力登记册。
重症肌无力的患病率为32.89×10居民(95%置信区间,23.86 - 41.91)。标准化患病率(欧洲人群)为35.47×10居民(95%置信区间,26.10 - 44.84)。女性与男性的比例为1.3。总体而言,65岁以上的患者组占所有病例的62.75%。重症肌无力的患病率在老年人群中显著增加。25岁以下患者中未登记到病例,25至64岁年龄组的患病率为21.87×10,65岁以上患者的患病率增至122.35×10。65岁及以下患者与65岁及以上患者在治疗前和截止日期的临床特征相似(P>0.05)。
这些数据显示了迄今为止报道的最高患病率。这种高患病率是由于在65岁以上患者中观察到的发病率。这些结果提供了一个新的警示,即重症肌无力在老年人群中可能未得到充分诊断。